---
title: "3. Some concepts on experimental design"
output:
    html_document:
      code_download: true
      theme: cosmo
      toc: true
      toc_float: true
      highlight: tango
      number_sections: true
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(include = TRUE, comment = NA, echo = TRUE,
                      message = FALSE, warning = FALSE)
library(tidyverse)
library(Rmisc)
library(NHANES)
```

```{r pop2Samp2Pop, out.width='80%',fig.asp=.8, fig.align='center',echo=FALSE}
if ("pi"%in%ls()) rm("pi")
kopvoeter<-function(x,y,angle=0,l=.2,cex.dot=.5,pch=19,col="black")
{
angle=angle/180*pi
points(x,y,cex=cex.dot,pch=pch,col=col)
lines(c(x,x+l*cos(-pi/2+angle)),c(y,y+l*sin(-pi/2+angle)),col=col)
lines(c(x+l/2*cos(-pi/2+angle),x+l/2*cos(-pi/2+angle)+l/4*cos(angle)),c(y+l/2*sin(-pi/2+angle),y+l/2*sin(-pi/2+angle)+l/4*sin(angle)),col=col)
lines(c(x+l/2*cos(-pi/2+angle),x+l/2*cos(-pi/2+angle)+l/4*cos(pi+angle)),c(y+l/2*sin(-pi/2+angle),y+l/2*sin(-pi/2+angle)+l/4*sin(pi+angle)),col=col)
lines(c(x+l*cos(-pi/2+angle),x+l*cos(-pi/2+angle)+l/2*cos(-pi/2+pi/4+angle)),c(y+l*sin(-pi/2+angle),y+l*sin(-pi/2+angle)+l/2*sin(-pi/2+pi/4+angle)),col=col)
lines(c(x+l*cos(-pi/2+angle),x+l*cos(-pi/2+angle)+l/2*cos(-pi/2-pi/4+angle)),c(y+l*sin(-pi/2+angle),y+l*sin(-pi/2+angle)+l/2*sin(-pi/2-pi/4+angle)),col=col)
}

par(mar=c(0,0,0,0),mai=c(0,0,0,0))
plot(0,0,xlab="",ylab="",xlim=c(0,10),ylim=c(0,10),col=0,xaxt="none",yaxt="none",axes=FALSE)
rect(0,6,10,10,border="red",lwd=2)
text(.5,8,"population",srt=90,col="red",cex=2)
symbols (3, 8, circles=1.5, col="red",add=TRUE,fg="red",inches=FALSE,lwd=2)
set.seed(330)
grid=seq(0,1.3,.01)

for (i in 1:50)
{
	angle1=runif(n=1,min=0,max=360)
	angle2=runif(n=1,min=0,max=360)
	radius=sample(grid,prob=grid^2*pi/sum(grid^2*pi),size=1)
	kopvoeter(3+radius*cos(angle1/180*pi),8+radius*sin(angle1/180*pi),angle=angle2)
}
text(7.5,8,"Cholestorol in population",col="red",cex=1.2)

rect(0,0,10,4,border="blue",lwd=2)
text(.5,2,"sample",srt=90,col="blue",cex=2)
symbols (3, 2, circles=1.5, col="red",add=TRUE,fg="blue",inches=FALSE,lwd=2)
for (i in 0:2)
	for (j in 0:4)
{

	kopvoeter(2.1+j*(3.9-2.1)/4,1.1+i)
}
text(7.5,2,"Cholestorol in sample",col="blue",cex=1.2)

arrows(3,5.9,3,4.1,col="black",lwd=3)
arrows(7,4.1,7,5.9,col="black",lwd=3)
text(1.5,5,"EXP. DESIGN (1)",col="black",cex=1.2)
text(8.5,5,"ESTIMATION &\nINFERENCE (3)",col="black",cex=1.2)
text(7.5,.5,"DATA EXPLORATION &\nDESCRIPTIVE STATISTICS (2)",col="black",cex=1.2)
```


#Need for a good control

- A good control group is crucial.

- To assess the effect of an intervention we need to compare a test and control group

- This is often not possible in a pretest/posttest design: e.g. effect before and after administring a drug without the use of a placebo group

- Groups in an observational study are often not comparable: advanced statistical methods are required to draw causal conclusions. 

- Double blinding

- We have to be aware of confounding!

- Randomized studies: random assignment of subjects in the study to the different treatment arms $\rightarrow$ comparable groups. 


# Randomisation

- Randomisation completely at random (no systematic allocation) 

## Simple randomisation

- Can lead to differences in the number of experimental units in each treatment arm 

- in 5% of the cases we might observe an imbalance of 
    - of at least 60:40 in a study with 100 subjects
    - of at least 531:469 in a study with 1000 subjects

- This imbalance is not problematic but causes a loss in precision. 

## Balanced randomisation

- Equal numbers of each treatment are assigned to a block of 2 or 4 patients. 
    - (1) AB, (2) BA
    - (1) AABB, (2) ABAB, (3) ABBA, (4) BABA, (5) BAAB, (6) BBAA

- Gebalanced randomisation ensures $\pm$ the same number of people in the control and the treatment arm of the experiment. 

- Does not make that we have an equal number of males with and without the treatment, etc.  

- In small studies it is possible that the groups are inbalanced in other characteristics (e.g. gender, race, age ...)

- This is not problematic because it occurs at random, but, again it causes a loss in precision. 

## Stratified randomization**

- The imbalance according to for instance gender can be avoided using stratified randomisation: balanced randomisatie per stratum

![Stratified Randomisatie](https://raw.githubusercontent.com/GTPB/PSLS20/gh-pages/assets/figs/stratification.png){ width=50% }

# Sample size 

- The sample size and the design are crucial 

- The larger the sample size the more precise the results


# Wrap-up

- Sample size is very important

- To assess the effect of a treatment we should compare comparable and representative groups of subjects with and without the treatment (a good control!). 

- In observational studies the researcher cannot choose the treatment. It was the patient or their MD who had chosen it 

- In experimental studies the researcher assigns the treatment 

- Confounding can be avoided via randomisation 

- We can also correct for confounding in the statistical analysis for the confounders that have been registered. 

